FDA Approval Status for Mohs Surgery

Mohs surgery is a procedure that is designed to remove cancerous skin cells that have yet to develop into large tumors or cysts. Developed by Dr. Frederick Mohs, this procedure is fully regulated and approved the FDA and is one of the most successful and accurate methods of treating these specific types of cancerous sections of skin.

Overview of Mohs Surgery

Mohs surgery involves the procedure of targeting the margins around the cancerous portion of skin cells in order to control and ultimately remove that section of cells. It is rated to up to a 99.7 percent success rate, although the specific conditions under which Mohs surgery must be performed are such that it can only be of use in very certain situations.

When Mohs Surgery Is Applicable

Mohs surgery is best used for small size basal cell carcinomas, although it can also be used to treat and remove squamous cell carcinomas as well. The success rate for this second option is significantly lower, and generally most dermatologists and surgeons recommend alternative means for removing these other types of skin cancer.

Mohs surgery has a low incidence of side effects that may include swelling, discoloration, pain and other related occurrences. Most patients are able to return to their daily activities within a few days of having the procedure completed, and the rate of return patients is very low. If you suspect that Mohs surgery may be helpful for you, or if you have any reason to believe that you may have a cancerous growth on your skin, speak with a professional or a dermatologist immediately for additional information and treatment options.

Have specific questions?

All Article Categories

Before & After Photos

Suggested Doctors

Recently Asked Questions